-
REAL-WORLD TREATMENT PATTERNS AND OUTCOMES IN PATIENTS WITH MUSCLE-INVASIVE BLADDER CANCER TREATED WITH RADICAL CYSTECTOMY BY CISPLATIN ELIGIBILITY STATUS: A US MULTICENTER CHART REVIEW STUDY
Mar 19, 2026, 15:42 PM -
ADVANCING COMPUTABLE OPERATIONAL DEFINITIONS WITH ONTOLOGY MAPPING AND SYNTHETIC DATA SIMULATION FOR MORE CONSISTENT REAL-WORLD EVIDENCE
Mar 18, 2026, 21:38 PM -
UNDERSTANDING THE HUMANISTIC BURDEN OF SJÖGREN’S DISEASE (SJD): A SYSTEMATIC LITERATURE REVIEW (SLR)
Mar 18, 2026, 21:38 PM -
ASSOCIATIONS BETWEEN SOCIAL MEDIA USAGE MOTIVATIONS, DEPENDENCY, AND OFFLINE SOCIAL OUTCOMES
Mar 18, 2026, 21:38 PM -
ASSESSING GENERIC PREFERENCE-BASED MEASURES FOR PROGRESSIVE SUPRANUCLEAR PALSY: A CONCEPT MAPPING APPROACH
Mar 18, 2026, 21:38 PM -
A MICROCOSTING STUDY OF CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION (CTEPH) BASED ON REAL WORLD DATA FROM BRAZIL
Mar 18, 2026, 21:38 PM -
ECONOMIC IMPACT OF VASOMOTOR SYMPTOMS AND DEPRESSION ON HEALTHCARE EXPENDITURES AMONG U.S. WOMEN
Mar 18, 2026, 21:38 PM -
PERIOD PREVALENCE OF MAJOR COMORBIDITIES FOLLOWING THE DIAGNOSIS OF GRAVES’ DISEASE: A NATIONWIDE COHORT STUDY IN SOUTH KOREA
Mar 18, 2026, 21:38 PM -
DEMOGRAPHIC DISPARITIES IN OPIOID USE DISORDER AND TREATMENT ACCESS DURING PREGNANCY AMONG KENTUCKY MEDICAID BENEFICIARIES
Mar 18, 2026, 21:38 PM -
HEALTH UTILITY VALUES AMONG MIDDLE-AGED AND OLDER ADULTS ACROSS SEVEN MAJOR GEOGRAPHICAL REGIONS IN CHINA: EVIDENCE FROM CHARLS 2020
Mar 18, 2026, 21:38 PM -
ASSESSING SELF-REPORTED HEALTH AND QUALITY OF LIFE IN ETHNICALLY DIVERSE CAREGIVERS FOR PEOPLE WITH AGITATION IN ALZHEIMER'S DEMENTIA
Mar 18, 2026, 21:38 PM -
ALGORITHMIC FAIRNESS IN MACHINE LEARNING PREDICTION FOR LONG-TERM ADJUVANT ENDOCRINE THERAPY ADHERENCE AMONG BREAST CANCER SURVIVORS
Mar 18, 2026, 21:38 PM -
DEMOGRAPHIC DISPARITIES IN HPV VACCINE INITIATION AMONG KENTUCKY MEDICAID BENEFICIARIES
Mar 18, 2026, 21:38 PM -
VALIDATION EVIDENCE OF HEALTHCARE UTILISATION MEASURES FOR PAEDIATRIC POPULATIONS: A SYSTEMATIC REVIEW
Mar 18, 2026, 21:38 PM -
INTEGRATING SOCIAL DETERMINANTS OF HEALTH INTO GLP-1 VALUE ASSESSMENT: A PROPOSED DISTRIBUTIONAL COST-EFFECTIVENESS ANALYSIS FRAMEWORK
Mar 18, 2026, 21:38 PM -
REAL-WORLD ADHERENCE TO GLP-1RA AND DUAL GIP-GLP-1RA AMONG COMMERCIALLY INSURED US PATIENTS WITH TYPE 2 DIABETES AND OBESITY
Mar 18, 2026, 21:38 PM -
REAL-WORLD ROS1 TESTING IN FIRST-LINE NON-SMALL CELL LUNG CANCER
Mar 18, 2026, 21:38 PM -
COST-BENEFIT ANALYSIS OF PHARMACIST-LED VIDEO TELEHEALTH MEDICATION THERAPY MANAGEMENT IN ADOLESCENTS AND YOUNG ADULTS WITH ASTHMA: A RANDOMIZED CONTROLLED TRIAL
Mar 18, 2026, 21:38 PM -
REPOSITIONING HEOR AS A RISK MITIGATION TOOL FOR HEALTHCARE INVESTMENT DECISION-MAKING: GOOD VALUE FOR MONEY?
Mar 18, 2026, 21:38 PM -
FLARE FREQUENCY, ORGAN DAMAGE, AND ECONOMIC BURDEN AMONG INDIVIDUALS WITH IMMUNOGLOBULIN G4-RELATED DISEASE (IGG4-RD) IN THE UNITED STATES
Mar 18, 2026, 21:38 PM
